BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 30061259)

  • 1. Cost-Effectiveness of Carbon Ion Radiation Therapy for Skull Base Chordoma Utilizing Long-Term (10-Year) Outcome Data.
    Sprave T; Verma V; Sterzing F; Bruckner T; Hees K; Land B; Jäkel O; Herfarth K; Debus J; Uhl M
    Anticancer Res; 2018 Aug; 38(8):4853-4858. PubMed ID: 30061259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the cost-effectiveness of Carbon ion radiation therapy for skull base chordoma.
    Jäkel O; Land B; Combs SE; Schulz-Ertner D; Debus J
    Radiother Oncol; 2007 May; 83(2):133-8. PubMed ID: 17490770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton and carbon ion radiotherapy in skull base chordomas: a prospective study based on a dual particle and a patient-customized treatment strategy.
    Iannalfi A; D'Ippolito E; Riva G; Molinelli S; Gandini S; Viselner G; Fiore MR; Vischioni B; Vitolo V; Bonora M; Ronchi S; Petrucci R; Barcellini A; Mirandola A; Russo S; Vai A; Mastella E; Magro G; Maestri D; Ciocca M; Preda L; Valvo F; Orecchia R
    Neuro Oncol; 2020 Sep; 22(9):1348-1358. PubMed ID: 32193546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A step towards international prospective trials in carbon ion radiotherapy: investigation of factors influencing dose distribution in the facilities in operation based on a case of skull base chordoma.
    Vogin G; Wambersie A; Koto M; Ohno T; Uhl M; Fossati P; Balosso J;
    Radiat Oncol; 2019 Feb; 14(1):24. PubMed ID: 30709366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of carbon-ion radiotherapy versus stereotactic body radiotherapy for non-small-cell lung cancer.
    Okazaki S; Shibuya K; Takura T; Miyasaka Y; Kawamura H; Ohno T
    Cancer Sci; 2022 Feb; 113(2):674-683. PubMed ID: 34820994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of 3-year vs 1-year adjuvant therapy with imatinib in patients with high risk of gastrointestinal stromal tumour recurrence in the Netherlands; a modelling study alongside the SSGXVIII/AIO trial.
    Majer IM; Gelderblom H; van den Hout WB; Gray E; Verheggen BG
    J Med Econ; 2013 Sep; 16(9):1106-19. PubMed ID: 23808902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes of skull base chordoma treated with high-dose carbon-ion radiotherapy.
    Koto M; Ikawa H; Kaneko T; Hagiwara Y; Hayashi K; Tsuji H
    Head Neck; 2020 Sep; 42(9):2607-2613. PubMed ID: 32472716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbon ion radiotherapy for skull base chordomas and chondrosarcomas: a systematic review and meta-analysis of local control, survival, and toxicity outcomes.
    Lu VM; O'Connor KP; Mahajan A; Carlson ML; Van Gompel JJ
    J Neurooncol; 2020 May; 147(3):503-513. PubMed ID: 32206977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The preliminary results of proton and carbon ion therapy for chordoma and chondrosarcoma of the skull base and cervical spine.
    Guan X; Gao J; Hu J; Hu W; Yang J; Qiu X; Hu C; Kong L; Lu JJ
    Radiat Oncol; 2019 Nov; 14(1):206. PubMed ID: 31752953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skull base chordomas: efficacy of surgery followed by carbon ion radiotherapy.
    Takahashi S; Kawase T; Yoshida K; Hasegawa A; Mizoe JE
    Acta Neurochir (Wien); 2009 Jul; 151(7):759-69. PubMed ID: 19434365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgery and proton radiation therapy for pediatric base of skull chordomas: Long-term clinical outcomes for 204 patients.
    Ioakeim-Ioannidou M; Niemierko A; Kim DW; Tejada A; Urell T; Leahy S; Adams J; Fullerton B; Nielsen GP; Hung YP; Shih AR; Patino M; Buch K; Rincon S; Kelly H; Cunnane MB; Tolia M; Widemann BC; Wedekind MF; John L; Ebb D; Shin JH; Cote G; Curry W; MacDonald SM
    Neuro Oncol; 2023 Sep; 25(9):1686-1697. PubMed ID: 37029730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas.
    Schulz-Ertner D; Karger CP; Feuerhake A; Nikoghosyan A; Combs SE; Jäkel O; Edler L; Scholz M; Debus J
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):449-57. PubMed ID: 17363188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose carbon-ion based radiotherapy of primary and recurrent sacrococcygeal chordomas: long-term clinical results of a single particle therapy center.
    Bostel T; Mattke M; Nicolay NH; Welzel T; Wollschläger D; Akbaba S; Mayer A; Sprave T; Debus J; Uhl M
    Radiat Oncol; 2020 Aug; 15(1):206. PubMed ID: 32831113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma.
    Kong L; Gao J; Hu J; Hu W; Guan X; Lu R; Lu JJ
    Chin J Cancer; 2016 Dec; 35(1):101. PubMed ID: 28007028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective clinical trial of proton therapy for chordoma and chondrosarcoma: Feasibility assessment.
    Baumann BC; Lustig RA; Mazzoni S; Grady SM; O'Malley BW; Lee JYK; Newman JG; Schuster JM; Both S; Lin A; Dorsey JF; Alonso-Basanta M
    J Surg Oncol; 2019 Aug; 120(2):200-205. PubMed ID: 31111502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of spot-scanning proton radiation therapy for chordoma and chondrosarcoma of the skull base: the Paul Scherrer Institut experience.
    Weber DC; Rutz HP; Pedroni ES; Bolsi A; Timmermann B; Verwey J; Lomax AJ; Goitein G
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):401-9. PubMed ID: 16168833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Societal implications of medical insurance coverage for imatinib as first-line treatment of chronic myeloid leukemia in China: a cost-effectiveness analysis.
    Sheng G; Chen S; Dong C; Zhang R; Miao M; Wu D; Tan SC; Liu C; Xiong T
    J Med Econ; 2017 Apr; 20(4):371-381. PubMed ID: 27936995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment outcomes of proton or carbon ion therapy for skull base chordoma: a retrospective study.
    Takagi M; Demizu Y; Nagano F; Terashima K; Fujii O; Jin D; Mima M; Niwa Y; Katsui K; Suga M; Yamashita T; Akagi T; Sakata KI; Fuwa N; Okimoto T
    Radiat Oncol; 2018 Nov; 13(1):232. PubMed ID: 30477528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton radiation therapy for chordomas and chondrosarcomas of the skull base.
    Hug EB; Slater JD
    Neurosurg Clin N Am; 2000 Oct; 11(4):627-38. PubMed ID: 11082173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Oncologic Outcomes and Treatment-Related Toxicity of Carbon Ion Radiotherapy and En Bloc Resection for Sacral Chordoma.
    Yolcu YU; Zreik J; Wahood W; Bhatti AUR; Bydon M; Houdek MT; Rose PS; Mahajan A; Petersen IA; Haddock MG; Ahmed SK; Laack NN; Jethwa K; Jeans EB; Imai R; Yamada S; Foote RL
    JAMA Netw Open; 2022 Jan; 5(1):e2141927. PubMed ID: 34994795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.